<scp>ST2</scp> and <scp>CSF</scp> ‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study-Reference-Cited by-同舟云学术

ST2 and CSF ‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study

Published:2022-11-13 Issue:2 Volume:16 Page:236-245
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Mi Jiarui¹²,Wu Xia³,Bai Xiaoyin¹,Yang Yang⁴,Yang Hong¹

Affiliation:

1. Department of Gastroenterology, Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China

2. Graduate School Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Department of Medicine Tufts Medical Center Massachusetts Boston USA

4. Department of Pharmacy, Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13442

Reference54 articles.

1. Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists

2. Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy

3. New biologics and small molecules in inflammatory bowel disease: an update

4. Serum Biomarkers for Inflammatory Bowel Disease

5. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mendelian randomisation analysis for intestinal disease: achievement and future;eGastroenterology;2024-06

2. Protein-centric omics integration analysis identifies candidate plasma proteins for multiple autoimmune diseases;Human Genetics;2023-12-24

3. Multiomics-based causal inference identifies novel therapeutic targets for inflammatory bowel disease in East Asians;2023-11-23